Baudax Bio Announces $17.6 Million Offering Priced At-the-Market under Nasdaq Rules Feb 08, 2021 3:24pm EST
Baudax Bio Announces Exercise of Warrants for Gross Proceeds of $13.4 Million Jan 21, 2021 9:28am EST
Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference Nov 30, 2020 4:05pm EST
Baudax Bio Announces Publication of ANJESO® Network Meta-Analysis in the Peer-Reviewed Journal BMC Anesthesiology Nov 20, 2020 7:00am EST
Baudax Bio to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020 Nov 02, 2020 7:05am EST
